ABX trades 82.4% below Wall Street's consensus target of $12.13.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ABX achieves its forward estimates and maintains a stable P/E multiple of 6.7x. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 18, 2026, Abacus Global Management, Inc. (ABX) has a Wall Street consensus price target of $12.13, based on estimates from 2 covering analysts. With the stock currently trading at $6.65, this represents a potential upside of +82.4%. The company has a market capitalization of $650M.
Analyst price targets range from a low of $9.00 to a high of $15.00, representing a 49% spread in expectations. The median target of $12.25 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ABX trades at a trailing P/E of 18.7x and forward P/E of 6.7x. The forward PEG ratio of 0.07 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +180.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $8.48, with bear and bull scenarios of $5.35 and $11.18 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
LPLALPL Financial Holdings Inc. | $22.5B | $281.51 | $402.25 | +42.9% | Buy | 12.0x | 27 |
HIFSHingham Institution for Savings | $627M | $287.50 | — | — | — | 20.5x | — |
CRBGCorebridge Financial, Inc. | $15.6B | $34.93 | $40.33 | +15.5% | Buy | 7.7x | 18 |
GLGlobe Life Inc. | $12.3B | $158.04 | $174.60 | +10.5% | Hold | 10.2x | 28 |
CNOCNO Financial Group, Inc. | $5.3B | $56.58 | $57.67 | +1.9% | Hold | 10.5x | 17 |
FGF&G Annuities & Life, Inc. | $3.0B | $22.73 | $24.00 | +5.6% | Hold | 7.8x | 9 |
PFGPrincipal Financial Group, Inc. | $24.1B | $111.35 | $107.33 | -3.6% | Hold | 12.1x | 25 |
RGAReinsurance Group of America, Incorporated | $17.6B | $268.29 | $276.20 | +2.9% | Buy | 8.6x | 23 |
METMetLife, Inc. | $65.3B | $101.50 | $108.25 | +6.7% | Buy | 9.9x | 33 |
PRUPrudential Financial, Inc. | $42.5B | $122.34 | $108.86 | -11.0% | Hold | 8.9x | 37 |
Quick answers to the most common questions about buying ABX stock.
The consensus Wall Street price target for ABX is $12.13, representing 82.4% upside from the current price of $6.65. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ABX has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $12.13 implies 82.4% upside from current levels.
With a forward P/E of 6.6633x, ABX trades at a relatively low valuation. The consensus target of $12.13 implies 82.4% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $15 for ABX, while the most conservative target is $9. The consensus of $12.13 represents the median expectation. Our quantitative valuation model projects a bull case target of $11 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
ABX is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ABX stock forecast based on 2 Wall Street analysts shows a consensus price target of $12.13, with estimates ranging from $9 (bear case) to $15 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $8, with bear/bull scenarios of $5/$11.
Our quantitative valuation model calculates ABX's fair value at $8 (base case), with a bear case of $5 and bull case of $11. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.
ABX trades at a forward P/E ratio of 6.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 18.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on ABX, with a "Buy" consensus rating and $12.13 price target (82.4% upside). 2 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ABX analyst price targets range from $9 to $15, a 49% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $12.13 consensus represents the middle ground. Our model's $5-$11 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.